A large number of evidences indicate that cortactin is overexpressed in various types of human cancers [47], such as head, neck, and esophageal squamous carcinomas, colorectal carcinoma, gastric cancer, hepatocellular cancer, breast cancer, and ovarian cancers [9, 110–113]. This evidence concerns the gene CTTN and breast cancer.